Protecting the normal in order to better kill the cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 2045-7634|4|9|1394-1403

ISSN： 2045-7634

Source： Cancer Medicine, Vol.4, Iss.9, 2015-09, pp. : 1394-1403

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Desferri-exochelin induces death by apoptosis in human breast cancer cells but does not kill normal breast cells

By Pahl P.M.B.  

Breast Cancer Research and Treatment, Vol. 69, Iss. 1, 2001-09 ,pp. : 69-79

Springer Publishing Company

Access to resources Recommend Favorite

RECRUIT-TandAbs®: harnessing the immune system to kill cancer cells

By McAleese Fionnuala   Eser Markus  

Future Oncology, Vol. 8, Iss. 6, 2012-06 ,pp. : 687-695

Future Medicine

Access to resources Recommend Favorite

Chemotherapy of Metastatic Breast Cancer: Is more better?

By Jassem Jacek  

Breast Cancer Research and Treatment, Vol. 81, Iss. 1, 2003-01 ,pp. : 37-42

Springer Publishing Company

Access to resources Recommend Favorite

''What Doesn't Kill You Makes You Stronger'': An Ovarian Cancer Survivor Survey

By Stewart D.E.   Wong F.   Duff S.   Melancon C.H.   Cheung A.M.  

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 537-542

Elsevier

Access to resources Recommend Favorite

Aging and cancer: can mTOR inhibitors kill two birds with one drug?

By Sharp Zelton  

Targeted Oncology, Vol. 6, Iss. 1, 2011-03 ,pp. : 41-51

Springer Publishing Company

Access to resources Recommend Favorite